Current Opinion in Neurology

Papers
(The TQCC of Current Opinion in Neurology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation90
Update on management of cerebral venous thrombosis85
Management of neuropsychiatric symptoms in dementia53
Assessing treatment response in multiple sclerosis52
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis52
Neuro-oncology is moving quickly toward new horizons of diagnosis and treatment49
Editorial introductions49
Historical development and contemporary use of neuromodulation in human spinal cord injury45
Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population42
Neurosyphilis in 2025: Erratum41
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies39
Central nervous system adverse events of immune checkpoint inhibitors37
Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond35
The role of the gut microbiome in Alzheimer's disease pathophysiology30
Gene therapies for CMT neuropathies: from the bench to the clinic30
Hereditary motor neuropathies30
The 2021 WHO classification of central nervous system tumors: what neurologists need to know29
Neurology education in the era of artificial intelligence29
Editorial introductions28
Editorial: Epilepsy advances in 202327
Multiple sclerosis in China: the current state of diagnosis and management27
Updates in neuro-otology27
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial26
Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention25
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise25
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms24
Threat of resurgence or hope for global eradication of poliovirus?24
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke24
Update on the clinical and therapeutic aspects of myotonic dystrophy type 124
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery24
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management24
The FSHD jigsaw: are we placing the tiles in the right position?23
Clinical impact of molecular profiling in rare brain tumors23
Levodopa infusion therapies for Parkinson disease23
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment22
Red flags in multiple sclerosis22
Global to individual: key domains of burden in pediatric headache22
Thymectomy in myasthenia gravis22
Nerve ultrasound in the diagnosis of inflammatory neuropathies22
Migraine in women: a review22
Update on dermatomyositis21
fMRI-based spatio-temporal parcellations of the human brain21
Diet and migraine: what is proven?21
MRI for the diagnosis of limb girdle muscular dystrophies20
Idiopathic intracranial hypertension: expanding our understanding20
Gauging and controlling excitability in cortical disorders20
Electrical stimulation of the peripheral and central vestibular system19
MRI in multiple sclerosis: progress in in-vivo pathobiology19
Acute stroke care in low and middle-income countries19
Parkinson's disease – genetic cause19
Novel pharmacological therapies in development19
Editorial: The gap between academic advances and therapy development in motor neuron disease18
Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities: Erratum18
Targeting IDH1/IDH2 mutations in gliomas18
Obesity-related neuropathy: the new epidemic18
New developments in diagnostics and treatment of adult-onset focal dystonia17
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies17
Novel approaches to treatment of leptomeningeal metastases17
Editorial introductions17
Progress in spinal muscular atrophy research17
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications17
Recent advances in Alzheimer disease genetics16
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis16
Neuroinflammation and immunometabolism in neurodegenerative diseases16
Optic neuritis: current challenges in diagnosis and management16
Neurosyphilis in 202516
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers16
Autoimmune encephalitis and paraneoplastic neurologic syndrome: clinical diagnosis15
Recent insights in striated muscle laminopathies15
Monitoring multiple sclerosis: digital and fluid phase biomarkers15
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management15
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond15
New insights in the immune treatment of Guillain–Barré syndrome15
Update on genetics of amyotrophic lateral sclerosis15
The state of art on the use of patient reported outcomes in migraine15
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health15
Current trend in air pollution exposure and stroke14
Update on modifiable risk factors for Alzheimer's disease and related dementias14
Diagnosing viral encephalitis and emerging concepts14
Abnormal energy metabolism in ALS: a key player?14
Sex and gender differences in neurological infections14
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders14
The monoaminergic systems as drivers of Alzheimer's disease pathophysiology and symptomatology14
PET imaging of microglial pathology in multiple sclerosis14
Imaging cortical lesions in multiple sclerosis14
Editorial introductions13
Vestibular migraine. Clinical and diagnostic challenges, and emerging therapeutic approaches13
Converging perspectives in vestibular neurology13
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease13
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum13
Imaging of vestibular function and disorders and its clinical relevance13
Precision medicine in Moyamoya vasculopathy13
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease: Erratum12
Editorial: Seizure disorders: 2023 update12
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy12
Peripheral visual field loss and activities of daily living12
Long COVID and especially headache syndromes12
Current gaps in acute reperfusion therapies12
Genetic role in autoimmune encephalitis and paraneoplastic neurological syndromes12
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review12
Muscle ultrasound in myopathies12
Deep brain stimulation of the mesencephalic locomotor region or lateral hypothalamus for facilitation of walking after spinal cord injury12
Immune checkpoint inhibitors induced side effects of the peripheral nervous system12
0.17864108085632